世界の合成血液代替物市場2021-2026:ヘモグロビンベース酸素運搬体(HBOC)、パーフルオロカーボン(PFC)、その他

LP Informationが発行した調査報告書(LPI21MY9290)
◆英語タイトル:Global Synthetic Blood Substitutes Market Growth 2021-2026
◆商品コード:LPI21MY9290
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年5月(※2024年版があります。お問い合わせください)
◆ページ数:134
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医療装置
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LPインフォメーション社の「合成血液代替物の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ヘモグロビンベース酸素運搬体(HBOC)、パーフルオロカーボン(PFC)、その他など、用途別には、心血管疾患、貧血、悪性新生物、怪我&外傷、新生児状態、母体状態、臓器移植、その他などにセグメント区分してまとめました。合成血液代替物のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・合成血液代替物の世界市場概要(サマリー)
・合成血液代替物の企業別販売量・売上
・合成血液代替物の企業別市場シェア
・合成血液代替物の世界市場規模 2016年-2021年:種類別(ヘモグロビンベース酸素運搬体(HBOC)、パーフルオロカーボン(PFC)、その他)
・合成血液代替物の世界市場規模 2016年-2021年:用途別(心血管疾患、貧血、悪性新生物、怪我&外傷、新生児状態、母体状態、臓器移植、その他)
・合成血液代替物の南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・合成血液代替物のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・合成血液代替物のヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・合成血液代替物の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・合成血液代替物市場の成長要因・課題・動向
・合成血液代替物の世界市場予測 2021年-2026年
・合成血液代替物の南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・合成血液代替物のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・合成血液代替物のヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・合成血液代替物の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・合成血液代替物の世界市場予測:種類別(ヘモグロビンベース酸素運搬体(HBOC)、パーフルオロカーボン(PFC)、その他)
・合成血液代替物の世界市場予測:用途別(心血管疾患、貧血、悪性新生物、怪我&外傷、新生児状態、母体状態、臓器移植、その他)
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Synthetic Blood Substitutes will have significant change from previous year. By the most conservative estimates of global Synthetic Blood Substitutes market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Synthetic Blood Substitutes market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Synthetic Blood Substitutes market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Hemoglobin-Based Oxygen Carriers (HBOCs)
Perfluorocarbon (PFCs)
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Cardiovascular Diseases
Anemia
Malignant Neoplasm
Injuries and Trauma
Neonatal Conditions
Maternal Conditions
Organ Transplant
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Hemarina
Sagart Corporation
FLUORO2 Therapeutics
Biopure Corporation
Alpha Therapeutic Corporation
KaloCyte
Baxter
Green Cross Corporation
North Field Laboratories
Alliance Pharmaceutical Corporation

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Synthetic Blood Substitutes Consumption 2016-2026
2.1.2 Synthetic Blood Substitutes Consumption CAGR by Region
2.2 Synthetic Blood Substitutes Segment by Type
2.2.1 Hemoglobin-Based Oxygen Carriers (HBOCs)
2.2.2 Perfluorocarbon (PFCs)
2.2.3 Others
2.3 Synthetic Blood Substitutes Sales by Type
2.3.1 Global Synthetic Blood Substitutes Sales Market Share by Type (2016-2021)
2.3.2 Global Synthetic Blood Substitutes Revenue and Market Share by Type (2016-2021)
2.3.3 Global Synthetic Blood Substitutes Sale Price by Type (2016-2021)
2.4 Synthetic Blood Substitutes Segment by Application
2.4.1 Cardiovascular Diseases
2.4.2 Anemia
2.4.3 Malignant Neoplasm
2.4.4 Injuries and Trauma
2.4.5 Neonatal Conditions
2.4.6 Maternal Conditions
2.4.7 Organ Transplant
2.4.8 Others
2.5 Synthetic Blood Substitutes Sales by Application
2.5.1 Global Synthetic Blood Substitutes Sale Market Share by Application (2016-2021)
2.5.2 Global Synthetic Blood Substitutes Revenue and Market Share by Application (2016-2021)
2.5.3 Global Synthetic Blood Substitutes Sale Price by Application (2016-2021)

3 Global Synthetic Blood Substitutes by Company
3.1 Global Synthetic Blood Substitutes Sales Market Share by Company
3.1.1 Global Synthetic Blood Substitutes Sales by Company (2019-2021)
3.1.2 Global Synthetic Blood Substitutes Sales Market Share by Company (2019-2021)
3.2 Global Synthetic Blood Substitutes Revenue Market Share by Company
3.2.1 Global Synthetic Blood Substitutes Revenue by Company (2019-2021)
3.2.2 Global Synthetic Blood Substitutes Revenue Market Share by Company (2019-2021)
3.3 Global Synthetic Blood Substitutes Sale Price by Company
3.4 Global Manufacturers Synthetic Blood Substitutes Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Synthetic Blood Substitutes Product Location Distribution
3.4.2 Players Synthetic Blood Substitutes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Synthetic Blood Substitutes by Region
4.1 Global Synthetic Blood Substitutes by Region
4.1.1 Global Synthetic Blood Substitutes Sales by Region
4.1.2 Global Synthetic Blood Substitutes Revenue by Region
4.2 Americas Synthetic Blood Substitutes Sales Growth
4.3 APAC Synthetic Blood Substitutes Sales Growth
4.4 Europe Synthetic Blood Substitutes Sales Growth
4.5 Middle East & Africa Synthetic Blood Substitutes Sales Growth

5 Americas
5.1 Americas Synthetic Blood Substitutes Sales by Country
5.1.1 Americas Synthetic Blood Substitutes Sales by Country (2016-2021)
5.1.2 Americas Synthetic Blood Substitutes Revenue by Country (2016-2021)
5.2 Americas Synthetic Blood Substitutes Sales by Type
5.3 Americas Synthetic Blood Substitutes Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Synthetic Blood Substitutes Sales by Region
6.1.1 APAC Synthetic Blood Substitutes Sales by Region (2016-2021)
6.1.2 APAC Synthetic Blood Substitutes Revenue by Region (2016-2021)
6.2 APAC Synthetic Blood Substitutes Sales by Type
6.3 APAC Synthetic Blood Substitutes Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Synthetic Blood Substitutes by Country
7.1.1 Europe Synthetic Blood Substitutes Sales by Country (2016-2021)
7.1.2 Europe Synthetic Blood Substitutes Revenue by Country (2016-2021)
7.2 Europe Synthetic Blood Substitutes Sales by Type
7.3 Europe Synthetic Blood Substitutes Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Synthetic Blood Substitutes by Country
8.1.1 Middle East & Africa Synthetic Blood Substitutes Sales by Country (2016-2021)
8.1.2 Middle East & Africa Synthetic Blood Substitutes Revenue by Country (2016-2021)
8.2 Middle East & Africa Synthetic Blood Substitutes Sales by Type
8.3 Middle East & Africa Synthetic Blood Substitutes Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Synthetic Blood Substitutes Distributors
10.3 Synthetic Blood Substitutes Customer

11 Global Synthetic Blood Substitutes Market Forecast
11.1 Global Synthetic Blood Substitutes Forecast by Region
11.1.1 Global Synthetic Blood Substitutes Forecast by Regions (2021-2026)
11.2.2 Global Synthetic Blood Substitutes Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Synthetic Blood Substitutes Forecast by Type
11.7 Global Synthetic Blood Substitutes Forecast by Application

12 Key Players Analysis
12.1 Hemarina
12.1.1 Hemarina Hemarina Company Information
12.1.2 Hemarina Synthetic Blood Substitutes Product Offered
12.1.3 Hemarina Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Hemarina Main Business Overview
12.1.5 Hemarina Latest Developments
12.2 Sagart Corporation
12.2.1 Sagart Corporation Company Information
12.2.2 Sagart Corporation Synthetic Blood Substitutes Product Offered
12.2.3 Sagart Corporation Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Sagart Corporation Main Business Overview
12.2.5 Sagart Corporation Latest Developments
12.3 FLUORO2 Therapeutics
12.3.1 FLUORO2 Therapeutics Company Information
12.3.2 FLUORO2 Therapeutics Synthetic Blood Substitutes Product Offered
12.3.3 FLUORO2 Therapeutics Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 FLUORO2 Therapeutics Main Business Overview
12.3.5 FLUORO2 Therapeutics Latest Developments
12.4 Biopure Corporation
12.4.1 Biopure Corporation Company Information
12.4.2 Biopure Corporation Synthetic Blood Substitutes Product Offered
12.4.3 Biopure Corporation Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Biopure Corporation Main Business Overview
12.4.5 Biopure Corporation Latest Developments
12.5 Alpha Therapeutic Corporation
12.5.1 Alpha Therapeutic Corporation Company Information
12.5.2 Alpha Therapeutic Corporation Synthetic Blood Substitutes Product Offered
12.5.3 Alpha Therapeutic Corporation Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Alpha Therapeutic Corporation Main Business Overview
12.5.5 Alpha Therapeutic Corporation Latest Developments
12.6 KaloCyte
12.6.1 KaloCyte Company Information
12.6.2 KaloCyte Synthetic Blood Substitutes Product Offered
12.6.3 KaloCyte Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 KaloCyte Main Business Overview
12.6.5 KaloCyte Latest Developments
12.7 Baxter
12.7.1 Baxter Company Information
12.7.2 Baxter Synthetic Blood Substitutes Product Offered
12.7.3 Baxter Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Baxter Main Business Overview
12.7.5 Baxter Latest Developments
12.8 Green Cross Corporation
12.8.1 Green Cross Corporation Company Information
12.8.2 Green Cross Corporation Synthetic Blood Substitutes Product Offered
12.8.3 Green Cross Corporation Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Green Cross Corporation Main Business Overview
12.8.5 Green Cross Corporation Latest Developments
12.9 North Field Laboratories
12.9.1 North Field Laboratories Company Information
12.9.2 North Field Laboratories Synthetic Blood Substitutes Product Offered
12.9.3 North Field Laboratories Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 North Field Laboratories Main Business Overview
12.9.5 North Field Laboratories Latest Developments
12.10 Alliance Pharmaceutical Corporation
12.10.1 Alliance Pharmaceutical Corporation Company Information
12.10.2 Alliance Pharmaceutical Corporation Synthetic Blood Substitutes Product Offered
12.10.3 Alliance Pharmaceutical Corporation Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Alliance Pharmaceutical Corporation Main Business Overview
12.10.5 Alliance Pharmaceutical Corporation Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Synthetic Blood Substitutes Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Hemoglobin-Based Oxygen Carriers (HBOCs)
Table 3. Major Players of Perfluorocarbon (PFCs)
Table 4. Major Players of Others
Table 5. Global Synthetic Blood Substitutes Sales by Type (2016-2021) & (Kiloton)
Table 6. Global Synthetic Blood Substitutes Sales Market Share by Type (2016-2021)
Table 7. Global Synthetic Blood Substitutes Revenue by Type (2016-2021) & ($ million)
Table 8. Global Synthetic Blood Substitutes Revenue Market Share by Type (2016-2021)
Table 9. Global Synthetic Blood Substitutes Sale Price by Type (2016-2021)
Table 10. Global Synthetic Blood Substitutes Sales by Application (2016-2021) & (Kiloton)
Table 11. Global Synthetic Blood Substitutes Sales Market Share by Application (2016-2021)
Table 12. Global Synthetic Blood Substitutes Value by Application (2016-2021)
Table 13. Global Synthetic Blood Substitutes Revenue Market Share by Application (2016-2021)
Table 14. Global Synthetic Blood Substitutes Sale Price by Application (2016-2021)
Table 15. Global Synthetic Blood Substitutes Sales by Company (2019-2021) & (Kiloton)
Table 16. Global Synthetic Blood Substitutes Sales Market Share by Company (2019-2021)
Table 17. Global Synthetic Blood Substitutes Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Synthetic Blood Substitutes Revenue Market Share by Company (2019-2021)
Table 19. Global Synthetic Blood Substitutes Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Synthetic Blood Substitutes Producing Area Distribution and Sales Area
Table 21. Players Synthetic Blood Substitutes Products Offered
Table 22. Synthetic Blood Substitutes Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Synthetic Blood Substitutes Sales by Region (2016-2021) (Kiloton)
Table 26. Global Synthetic Blood Substitutes Sales Market Share by Region (2016-2021)
Table 27. Global Synthetic Blood Substitutes Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Synthetic Blood Substitutes Revenue Market Share by Region (2016-2021)
Table 29. Americas Synthetic Blood Substitutes Sales by Country (2016-2021) & (Kiloton)
Table 30. Americas Synthetic Blood Substitutes Sales Market Share by Country (2016-2021)
Table 31. Americas Synthetic Blood Substitutes Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Synthetic Blood Substitutes Revenue Market Share by Country (2016-2021)
Table 33. Americas Synthetic Blood Substitutes Sales by Type (2016-2021) & (Kiloton)
Table 34. Americas Synthetic Blood Substitutes Sales Market Share by Type (2016-2021)
Table 35. Americas Synthetic Blood Substitutes Sales by Application (2016-2021) & (Kiloton)
Table 36. Americas Synthetic Blood Substitutes Sales Market Share by Application (2016-2021)
Table 37. APAC Synthetic Blood Substitutes Sales by Region (2016-2021) & (Kiloton)
Table 38. APAC Synthetic Blood Substitutes Sales Market Share by Region (2016-2021)
Table 39. APAC Synthetic Blood Substitutes Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Synthetic Blood Substitutes Revenue Market Share by Region (2016-2021)
Table 41. APAC Synthetic Blood Substitutes Sales by Type (2016-2021) & (Kiloton)
Table 42. APAC Synthetic Blood Substitutes Sales Market Share by Type (2016-2021)
Table 43. APAC Synthetic Blood Substitutes Sales by Application (2016-2021) & (Kiloton)
Table 44. APAC Synthetic Blood Substitutes Sales Market Share by Application (2016-2021)
Table 45. Europe Synthetic Blood Substitutes Sales by Country (2016-2021) & (Kiloton)
Table 46. Europe Synthetic Blood Substitutes Sales Market Share by Country (2016-2021)
Table 47. Europe Synthetic Blood Substitutes Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Synthetic Blood Substitutes Revenue Market Share by Country (2016-2021)
Table 49. Europe Synthetic Blood Substitutes Sales by Type (2016-2021) & (Kiloton)
Table 50. Europe Synthetic Blood Substitutes Sales Market Share by Type (2016-2021)
Table 51. Europe Synthetic Blood Substitutes Sales by Application (2016-2021) & (Kiloton)
Table 52. Europe Synthetic Blood Substitutes Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Synthetic Blood Substitutes Sales by Country (2016-2021) & (Kiloton)
Table 54. Middle East & Africa Synthetic Blood Substitutes Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Synthetic Blood Substitutes Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Synthetic Blood Substitutes Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Synthetic Blood Substitutes Sales by Type (2016-2021) & (Kiloton)
Table 58. Middle East & Africa Synthetic Blood Substitutes Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Synthetic Blood Substitutes Sales by Application (2016-2021) & (Kiloton)
Table 60. Middle East & Africa Synthetic Blood Substitutes Sales Market Share by Application (2016-2021)
Table 61. Global Synthetic Blood Substitutes Sales Forecast by Type (2021-2026) & (Kiloton)
Table 62. Global Synthetic Blood Substitutes Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Synthetic Blood Substitutes Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Synthetic Blood Substitutes Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Synthetic Blood Substitutes Sales Forecast by Application (2021-2026) & (Kiloton)
Table 66. Global Synthetic Blood Substitutes Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Synthetic Blood Substitutes Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Synthetic Blood Substitutes Revenue Market Share Forecast by Application (2021-2026)
Table 69. Hemarina Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 70. Hemarina Synthetic Blood Substitutes Product Offered
Table 71. Hemarina Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 72. Hemarina Main Business
Table 73. Hemarina Latest Developments
Table 74. Sagart Corporation Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 75. Sagart Corporation Synthetic Blood Substitutes Product Offered
Table 76. Sagart Corporation Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 77. Sagart Corporation Main Business
Table 78. Sagart Corporation Latest Developments
Table 79. FLUORO2 Therapeutics Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 80. FLUORO2 Therapeutics Synthetic Blood Substitutes Product Offered
Table 81. FLUORO2 Therapeutics Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 82. FLUORO2 Therapeutics Main Business
Table 83. FLUORO2 Therapeutics Latest Developments
Table 84. Biopure Corporation Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 85. Biopure Corporation Synthetic Blood Substitutes Product Offered
Table 86. Biopure Corporation Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 87. Biopure Corporation Main Business
Table 88. Biopure Corporation Latest Developments
Table 89. Alpha Therapeutic Corporation Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 90. Alpha Therapeutic Corporation Synthetic Blood Substitutes Product Offered
Table 91. Alpha Therapeutic Corporation Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 92. Alpha Therapeutic Corporation Main Business
Table 93. Alpha Therapeutic Corporation Latest Developments
Table 94. KaloCyte Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 95. KaloCyte Synthetic Blood Substitutes Product Offered
Table 96. KaloCyte Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 97. KaloCyte Main Business
Table 98. KaloCyte Latest Developments
Table 99. Baxter Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 100. Baxter Synthetic Blood Substitutes Product Offered
Table 101. Baxter Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 102. Baxter Main Business
Table 103. Baxter Latest Developments
Table 104. Green Cross Corporation Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 105. Green Cross Corporation Synthetic Blood Substitutes Product Offered
Table 106. Green Cross Corporation Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 107. Green Cross Corporation Main Business
Table 108. Green Cross Corporation Latest Developments
Table 109. North Field Laboratories Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 110. North Field Laboratories Synthetic Blood Substitutes Product Offered
Table 111. North Field Laboratories Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 112. North Field Laboratories Main Business
Table 113. North Field Laboratories Latest Developments
Table 114. Alliance Pharmaceutical Corporation Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 115. Alliance Pharmaceutical Corporation Synthetic Blood Substitutes Product Offered
Table 116. Alliance Pharmaceutical Corporation Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 117. Alliance Pharmaceutical Corporation Main Business
Table 118. Alliance Pharmaceutical Corporation Latest Developments
List of Figures
Figure 1. Picture of Synthetic Blood Substitutes
Figure 2. Synthetic Blood Substitutes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Synthetic Blood Substitutes Sales Growth Rate 2016-2026 (Kiloton)
Figure 7. Global Synthetic Blood Substitutes Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Synthetic Blood Substitutes Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Hemoglobin-Based Oxygen Carriers (HBOCs)
Figure 10. Product Picture of Perfluorocarbon (PFCs)
Figure 11. Product Picture of Others
Figure 12. Global Synthetic Blood Substitutes Sales Market Share by Type in 2020
Figure 13. Global Synthetic Blood Substitutes Revenue Market Share by Type (2016-2021)
Figure 14. Synthetic Blood Substitutes Consumed in Cardiovascular Diseases
Figure 15. Global Synthetic Blood Substitutes Market: Cardiovascular Diseases (2016-2021) & (Kiloton)
Figure 16. Synthetic Blood Substitutes Consumed in Anemia
Figure 17. Global Synthetic Blood Substitutes Market: Anemia (2016-2021) & (Kiloton)
Figure 18. Synthetic Blood Substitutes Consumed in Malignant Neoplasm
Figure 19. Global Synthetic Blood Substitutes Market: Malignant Neoplasm (2016-2021) & (Kiloton)
Figure 20. Synthetic Blood Substitutes Consumed in Injuries and Trauma
Figure 21. Global Synthetic Blood Substitutes Market: Injuries and Trauma (2016-2021) & (Kiloton)
Figure 22. Synthetic Blood Substitutes Consumed in Neonatal Conditions
Figure 23. Global Synthetic Blood Substitutes Market: Neonatal Conditions (2016-2021) & (Kiloton)
Figure 24. Synthetic Blood Substitutes Consumed in Maternal Conditions
Figure 25. Global Synthetic Blood Substitutes Market: Maternal Conditions (2016-2021) & (Kiloton)
Figure 26. Synthetic Blood Substitutes Consumed in Organ Transplant
Figure 27. Global Synthetic Blood Substitutes Market: Organ Transplant (2016-2021) & (Kiloton)
Figure 28. Synthetic Blood Substitutes Consumed in Others
Figure 29. Global Synthetic Blood Substitutes Market: Others (2016-2021) & (Kiloton)
Figure 30. Global Synthetic Blood Substitutes Sales Market Share by Application (2016-2021)
Figure 31. Global Synthetic Blood Substitutes Revenue Market Share by Application in 2020
Figure 32. Global Synthetic Blood Substitutes Revenue Market by Company in 2020 ($ Million)
Figure 33. Global Synthetic Blood Substitutes Revenue Market Share by Company in 2020
Figure 34. Global Synthetic Blood Substitutes Sales Market Share by Regions (2016-2021)
Figure 35. Global Synthetic Blood Substitutes Revenue Market Share by Region in 2020
Figure 36. Americas Synthetic Blood Substitutes Sales 2016-2021 (Kiloton)
Figure 37. Americas Synthetic Blood Substitutes Revenue 2016-2021 ($ Millions)
Figure 38. APAC Synthetic Blood Substitutes Sales 2016-2021 (Kiloton)
Figure 39. APAC Synthetic Blood Substitutes Revenue 2016-2021 ($ Millions)
Figure 40. Europe Synthetic Blood Substitutes Sales 2016-2021 (Kiloton)
Figure 41. Europe Synthetic Blood Substitutes Revenue 2016-2021 ($ Millions)
Figure 42. Middle East & Africa Synthetic Blood Substitutes Sales 2016-2021 (Kiloton)
Figure 43. Middle East & Africa Synthetic Blood Substitutes Revenue 2016-2021 ($ Millions)
Figure 44. Americas Synthetic Blood Substitutes Sales Market Share by Country in 2020
Figure 45. Americas Synthetic Blood Substitutes Revenue Market Share by Country in 2020
Figure 46. Americas Synthetic Blood Substitutes Sales Market Share by Type in 2020
Figure 47. Americas Synthetic Blood Substitutes Sales Market Share by Application in 2020
Figure 48. United States Synthetic Blood Substitutes Revenue Growth 2016-2021 ($ Millions)
Figure 49. Canada Synthetic Blood Substitutes Revenue Growth 2016-2021 ($ Millions)
Figure 50. Mexico Synthetic Blood Substitutes Revenue Growth 2016-2021 ($ Millions)
Figure 51. Brazil Synthetic Blood Substitutes Revenue Growth 2016-2021 ($ Millions)
Figure 52. APAC Synthetic Blood Substitutes Sales Market Share by Region in 2020
Figure 53. APAC Synthetic Blood Substitutes Revenue Market Share by Regions in 2020
Figure 54. APAC Synthetic Blood Substitutes Sales Market Share by Type in 2020
Figure 55. APAC Synthetic Blood Substitutes Sales Market Share by Application in 2020
Figure 56. China Synthetic Blood Substitutes Revenue Growth 2016-2021 ($ Millions)
Figure 57. Japan Synthetic Blood Substitutes Revenue Growth 2016-2021 ($ Millions)
Figure 58. Korea Synthetic Blood Substitutes Revenue Growth 2016-2021 ($ Millions)
Figure 59. Southeast Asia Synthetic Blood Substitutes Revenue Growth 2016-2021 ($ Millions)
Figure 60. India Synthetic Blood Substitutes Revenue Growth 2016-2021 ($ Millions)
Figure 61. Australia Synthetic Blood Substitutes Revenue Growth 2016-2021 ($ Millions)
Figure 62. Europe Synthetic Blood Substitutes Sales Market Share by Country in 2020
Figure 63. Europe Synthetic Blood Substitutes Revenue Market Share by Country in 2020
Figure 64. Europe Synthetic Blood Substitutes Sales Market Share by Type in 2020
Figure 65. Europe Synthetic Blood Substitutes Sales Market Share by Application in 2020
Figure 66. Germany Synthetic Blood Substitutes Revenue Growth 2016-2021 ($ Millions)
Figure 67. France Synthetic Blood Substitutes Revenue Growth 2016-2021 ($ Millions)
Figure 68. UK Synthetic Blood Substitutes Revenue Growth 2016-2021 ($ Millions)
Figure 69. Italy Synthetic Blood Substitutes Revenue Growth 2016-2021 ($ Millions)
Figure 70. Russia Synthetic Blood Substitutes Revenue Growth 2016-2021 ($ Millions)
Figure 71. Middle East & Africa Synthetic Blood Substitutes Sales Market Share by Country in 2020
Figure 72. Middle East & Africa Synthetic Blood Substitutes Revenue Market Share by Country in 2020
Figure 73. Middle East & Africa Synthetic Blood Substitutes Sales Market Share by Type in 2020
Figure 74. Middle East & Africa Synthetic Blood Substitutes Sales Market Share by Application in 2020
Figure 75. Egypt Synthetic Blood Substitutes Revenue Growth 2016-2021 ($ Millions)
Figure 76. South Africa Synthetic Blood Substitutes Revenue Growth 2016-2021 ($ Millions)
Figure 77. Israel Synthetic Blood Substitutes Revenue Growth 2016-2021 ($ Millions)
Figure 78. Turkey Synthetic Blood Substitutes Revenue Growth 2016-2021 ($ Millions)
Figure 79. GCC Country Synthetic Blood Substitutes Revenue Growth 2016-2021 ($ Millions)
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles


【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の合成血液代替物市場2021-2026:ヘモグロビンベース酸素運搬体(HBOC)、パーフルオロカーボン(PFC)、その他(Global Synthetic Blood Substitutes Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。